Editor’s Note
Amorepacific Holdings has invested in medical device firm Higher Corporation to jointly develop next-generation integrated solutions combining dermatological science and aesthetic technology.
Amorepacific Holdings has made a strategic investment in Higher Corporation, a medical aesthetic device company, to strengthen its presence in the beauty and medical sectors.
Amorepacific Holdings announced on the 27th that it has signed an investment agreement with Higher Corporation. Through this agreement, the two companies will pursue collaboration to develop next-generation beauty and medical solutions that bridge professional treatments and daily skincare.
The partnership will leverage Higher Corporation’s aesthetic medical device development capabilities, joint research with medical professionals, and global KOL network, combined with Amorepacific’s dermatological science research and skincare technology expertise, to collaborate across product planning, R&D, distribution, and marketing.
As part of this agreement, Amorepacific Holdings has made a strategic investment in Higher Corporation to further strengthen their mid-to-long-term cooperative relationship.
Initially, the two companies will focus on developing and commercializing skin boosters, cosmeceuticals, and medical devices for skin aesthetics; developing post-treatment aftercare products and collaborating on distribution to hospitals and clinics; and conducting joint R&D on raw materials and ingredients, as well as marketing activities.
Higher Corporation, founded in 2021, is a medical aesthetic device company that operates based on R&D through a medical professional network and global distribution capabilities. Its flagship product, HILOWAVE, is marketed in multiple countries including South Korea, Japan, Indonesia, and Vietnam.